Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes.
Fiche publication
Date publication
décembre 2005
Auteurs
Membres identifiés du Cancéropôle Est :
Pr VERGES Bruno
Tous les auteurs :
Betteridge DJ, Verges B
Lien Pubmed
Résumé
Aims/hypothesis: The aim of this study was to determine the long-term effects of pioglitazone add-on to metformin or sulphonylurea on plasma lipids and lipoproteins. Materials and methods: The effects of pioglitazone were studied in two clinical trials in patients with inadequately controlled type 2 diabetes (HbA(1)c >= 7.5 and
Référence
Diabetologia. 2005 Dec;48(12):2477-81